Section 2: Clinical and Administrative Domains
Section 3: Implementation Guides
HL7/NCPDP Informative Document: Pharmacist Consultation Note, Release 1
DESCRIPTION
The HL7/NCPDP Pharmacist Consultation Note guidance document addresses the unique pharmacy requirements when creating either C-CDA Consult Notes or C-CDA on FHIR Consultation Notes.
ALTERNATIVE NAMES
HL7/NCPDP Informative Document: Pharmacist Consultation Note, Release 1 may also go by the following names or acronyms:
"HL7/NCPDP Guidance: Consultant Pharmacist Consult Note Update, R1 - US Realm",
BENEFITS
- Provides guidance and best practices for creating pharmacist consultant notes
- Ensures that guidance and best practices are consistent across both C-CDA and FHIR technologies.
- Addresses additional documentation requirements found in some care settings, e.g., regulatory requirements for Long Term and Post Acute Care (LTPAC).
IMPLEMENTATIONS/CASE STUDIES
- Center for Medicare and Medicaid Services (CMS) requires consultant pharmacists in the Long Term and Post Acute Care (LTPAC) settings to exchange clinical recommendations based on a monthly drug regimen review (DRR) on every resident in the LTPAC setting. DRR documentation is a quality criteria for LTPAC Medication Management.
-
Pharmacists also provide consultive servies in
- inpatient settings (e.g., medication reconciliation, medication dosing and monitoring in renal impairment),
- clinical outpatient settings (e.g., medication management and education, poly-pharmacy assessment) and
- retail outpatient (e.g., medication management, therapeutic monitoring, patient education).
DEVELOPMENT BACKGROUND
The HL7/NCPDP Pharmacist Consultation Note guidance document is nominally based on a prior NCPDP guidance document. This document updates technical details, has additional use cases, and adds FHIR guidance.
RELATED DOCUMENTS
 |
HL7/NCPDP Informative Document: Pharmacist Consultation Note, Release 1 |
(Download) (1.03 MB) |
ADDITIONAL DETAILS
To submit feedback on this Informative document, follow this link to the Jira project associated with the specification.
TOPIC
- Pharmacy
BALLOT TYPE
- Informative
STATUS DATE
RESPONSIBLE WORK GROUP
PRODUCT TYPE
- Document
STAKEHOLDERS
- Health Care IT Vendors
- Healthcare Institutions
FAMILY
- Cross-paradigm
CURRENT STATE
- Active
REALM
- US Realm